You can sell prescription medicines to UK patients online without owning your own pharmacy — but only by partnering with a GPhC-registered pharmacy that handles the dispensing. The patient experience is yours; the regulated dispensing activity must sit with a pharmacy that has GPhC premises registration, a superintendent pharmacist, and the operational infrastructure to dispense lawfully. This piece walks through how the model works.

The regulated activity is dispensing — not the patient relationship

The activity that requires GPhC registration is the dispensing of medicines: receipt of prescription, pharmacist sign-off, picking, packing, supply to patient. The patient relationship — brand, marketing, consultation, ongoing engagement — does not itself require pharmacy registration.

This separation lets a telehealth brand operate patient-facing while a GPhC-registered partner pharmacy operates the regulated dispensing. The brand sells the service; the pharmacy dispenses. Both are commercial entities in the chain, with clear regulatory accountability for the regulated layer.

How the white-label partnership model works in practice

The brand handles: patient acquisition, consultation booking, brand experience, ongoing patient engagement, support. The partner pharmacy handles: prescription dispensing, pharmacist sign-off, picking and packing, courier handover, exception handling, pharmacovigilance capture, GPhC compliance, MHRA medicines handling.

The clinical layer — the prescribing — can be done by clinicians employed by the brand, contracted by the brand, or supplied by the white-label platform. PExpo's brand model includes the prescriber network alongside the dispensing operation, so the brand does not need to source prescribers separately.

What you still need on the brand side

Even without owning the pharmacy, the brand still needs: CQC registration for the clinical service in England, professional indemnity insurance covering the clinical work, UK GDPR compliance with appropriate DPIA, advertising compliance review for ASA and MHRA rules on POMs, and contracts with the partner pharmacy and any clinicians.

The brand-side regulatory work is meaningful but smaller in scope than the pharmacy-side work. It can typically be set up in weeks rather than months.

When you would want to own a pharmacy

Owning the dispensing pharmacy makes sense above 8,000-10,000 monthly dispenses or when category-specific reasons require operational control — controlled drug handling at scale, cold-chain capability that the partner cannot match, or strategic IP around dispensing technology. Below those thresholds, partnering is the right call.

Most UK telehealth brands launched in 2024-2026 use the partnership model. The ones that built their own pharmacy did so because they had reached scale or strategic reasons — not because they were starting from scratch.

How PExpo enables sales of prescription medicines without owning a pharmacy

PExpo's brand model packages the GPhC-registered dispensing, the UK prescriber network, and the clinical governance into a single integrated stack. Brands operate patient-facing under their own name; PExpo operates the regulated dispensing and prescribing layers behind the brand.

See our brand model page for what is included operationally, and our pricing page for the commercial structure including per-dispense terms.

Key takeaway

The activity requiring GPhC registration is the dispensing of medicines. The patient relationship — brand, marketing, consultation, engagement — does not itself require pharmacy registration.

The brand sells the service. The pharmacy dispenses. Clear regulatory accountability stays on the regulated layer.

You can sell prescription medicines to UK patients online without owning a pharmacy by partnering with a GPhC-registered pharmacy that handles the dispensing under proper regulatory accountability. The brand operates patient-facing; the pharmacy operates the regulated layer. See our brand model page for the white-label option and our pricing page for the commercial structure.

Frequently asked questions

Does the partner pharmacy need to be in the UK?

Yes — to dispense medicines to UK patients, the dispensing pharmacy must hold GPhC registration in Great Britain (or the equivalent for Northern Ireland) and operate from registered premises under a superintendent pharmacist.

Can the brand and the pharmacy share the same management?

Yes — common ownership of brand and pharmacy is permitted. What matters is that the pharmacy operates lawfully under GPhC oversight with appropriate governance. Many UK telehealth groups operate this way.

Does PExpo white-label the pharmacy for my brand?

Yes — PExpo's brand model includes GPhC-registered dispensing operating under the brand's customer-facing identity. The regulatory entity remains PExpo's pharmacy operation; the patient experience is the brand. See our brand model page.